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ABSTRACT
Objective To determine whether the repeatedly observed
low risk of ulcerative colitis after appendicectomy is
related to the appendicectomy itself or the underlying
morbidity, notably appendicitis or mesenteric
lymphadenitis.
Design Nationwide cohort studies.
Setting Sweden and Denmark.
Participants 709353 Swedish (1964-2004) and Danish
(1977-2004) patients who had undergone
appendicectomy were followed up for subsequent
ulcerative colitis. The impact of appendicectomy on risk
was also studied in 224483 people whose parents or
siblings had inflammatory bowel disease.
Main outcome measures Standardised incidence ratios
and rate ratios as measures of relative risk.
Results During 11.1 million years of follow-up in the
appendicectomy cohort, 1192 patients developed
ulcerative colitis (10.8 per 100000 person years).
Appendicectomy without underlying inflammation was
not associatedwithreducedrisk(standardisedincidence
ratio 1.04, 95% confidence interval 0.95 to 1.15). Before
the age of 20, however, appendicectomy for appendicitis
(0.45, 0.39 to 0.53) or mesenteric lymphadenitis (0.65,
0.46 to 0.90) was associated with significant risk
reduction. A similar pattern was seen in those with
affected relatives, whose overall risk of ulcerative colitis
was clearly higher than the background risk (1404
observed v 446 expected; standardised incidence ratio
3.15, 2.99 to 3.32). In this cohort, appendicectomy
without underlying appendicitis did not modify risk (rate
ratio 1.04,0.66 to 1.55, v noappendicectomy),while risk
after appendicectomy for appendicitis was halved (0.49,
0.31 to 0.74).
Conclusions In individuals with or without a familial
predisposition to inflammatory bowel disease,
appendicitis and mesenteric lymphadenitis during
childhood or adolescence are linked to a significantly
reduced risk of ulcerative colitis in adulthood.
Appendicectomyitselfdoesnotprotectagainstulcerative
colitis.
INTRODUCTION
Both inherited and environmental factors play impor-
tant parts in the aetiology of ulcerative colitis.
1
Although numerous non-inherited factors have been
proposed, however, few have been consistently asso-
ciated with risk. Surgical removal of the vermiform
appendix for suspected appendicitis, the single most
commonsurgicalemergency,isonesuchfactor.Many
case-control studies have linked appendicectomy to a
significantly reduced risk, typically with odds ratios
around 0.3, suggesting a reduction of about two thirds
in risk among people who have undergone
appendicectomy.
2 In two cohort studies based on
national register data we previously provided support
for an inverse association between appendicectomy
and risk,
34 but relative risk estimates were much less
extremethanthosereportedincase-controlstudies.To
gain new insights into the repeatedly observed inverse
association we expanded and combined our national
cohort data to cover all recorded appendicectomies in
Sweden and Denmark up to 2004. Thus, with a cohort
of well over 700000 patients from two countries, we
had unprecedented statistical power to address the
central question
5: is it appendicectomy itself or rather
the underlying morbidity (notably, appendicitis or
mesenteric lymphadenitis) that is responsible for the
reduced incidence of ulcerative colitis in people with a
history of appendicectomy?
METHODS
We used data from population based hospital dis-
charge registries in Sweden and Denmark to identify
patients who underwent appendicectomy and char-
acterise them according to underlying diagnoses, sex,
and age at the time of operation.
Appendicectomy cohort
Sweden—We identified 446968 patients who under-
went appendicectomyduringthe 41yearperiod1964-
2004. National operation codes for appendicectomy
included 4510, 4511, 4517, and 0058 in 1964-96 and
JEA00, JEA01, and JEA10 in 1997-2004. When
initiated in 1964, the Swedish Hospital Discharge
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by 1972 half of the Swedish population was covered
and since 1987 the registry has had complete national
coverage.
6Weexcluded304patients(0.07%)recorded
ashavingbothulcerativecolitisandCrohn’sdiseaseat
some point in 1964-2004, 574 patients (0.13%) with
ulcerativecolitisand350patients(0.08%)withCrohn’s
disease before the appendicectomy, 131 patients
(0.03%) with recorded ulcerative colitis and 1432
patients(0.32%) withrecordedCrohn’sdisease during
the hospital admission for appendicectomy, and 10
patients (0.002%) with recorded ulcerative colitis and
57 patients (0.01%) with recorded Crohn’s disease
between the date of discharge after appendicectomy
and the first day of the subsequent month. Finally, we
excluded349patients(0.08%)whodiedbeforethestart
of follow-up for ulcerative colitis on the first day in the
month after the appendicectomy. The resulting Swed-
ish cohort consisted of 443761 patients (245623
women and 198138 men), representing 99.3% of all
recorded appendicectomy patients in Sweden for
1964-2004.
Denmark—We identified 273099 patients who
underwent appendicectomy during the 28 year period
1977-2004. National operation codes for appendicect-
omy included 43000 and 43001 during the period
1977-95 and JEA00, JEA01, and JEA10 during the
period 1996-2004. The Danish Hospital Discharge
Register
7 has had virtually complete national coverage
regarding non-psychiatric hospital admissions since
1977. We excluded 2211 patients (0.81%) with non-
Danish nationalities, 406 patients (0.15%) with invalid
personal identifiers, and 1794 patients (0.66%) with
permanent residence outside Denmark at the time of
admission. We also excluded 142 patients (0.05%)
recorded as having both ulcerative colitis and Crohn’s
disease at some point during the period 1977-2004, 355
patients (0.13%) with ulcerative colitis and 243 patients
(0.09%) with Crohn’s disease before the appendicect-
omy,29patients(0.01%)withrecordedulcerativecolitis
and1766patients(0.65%)withrecordedCrohn’sdisease
during the hospital admission for appendicectomy, and
10 patients (0.004%)withrecordedulcerative colitis and
60 patients (0.02%) with recorded Crohn’sd i s e a s e
between the date of discharge after appendicectomy
and the first day of the subsequent month. Finally, we
excluded 477 patients (0.17%) who died and 14 patients
(0.005%) who emigrated from Denmark before the start
of follow-up for ulcerative colitis on the first day in the
month after the appendicectomy. The resulting Danish
cohort consisted of 265592 patients (152256 women
and 113336 men), corresponding to 97.3% of all
appendicectomy patients in Denmark for the period
1977-2004.
Coding—For each patient, the operation code for
appendicectomy was accompanied by codes for
relevant discharge diagnoses according to national
modifications of the international classification of
diseases (ICD) versions 7-10 in Sweden and versions
8 and 10 in Denmark. Using this information, we
categorised cohort members according to the most
likely underlying disease. Cohort members with
appendicitis were categorised as appendicitis with
perforation, including appendicitis with diffuse or
localised peritonitis and appendicitis with periappen-
dicular abscess, or appendicitis without perforation,
including all other and unspecified cases of appendi-
citis. For cohort members without appendicitis, cate-
gories comprised mesenteric lymphadenitis;
appendiceal disease except appendicitis, including
neoplasm,mucocele,lymphoidhyperplasia,invagina-
tion, fecalith, and fistula; unspecific abdominal pain;
and other and unspecified disease.
Familial predisposition
Toaddresstheroleofappendicectomyinpeoplewitha
geneticallyincreasedriskofulcerativecolitis,welinked
hospital admission data with family information in
Statistics Sweden
8 and the Danish Civil Registration
System,
9 continuously updated demographic data-
bases. We identified 164955 Swedes and 59528
Danes for whom a mother, a father, or a sibling had a
record of inflammatory bowel disease (ulcerative
colitis, Crohn’s disease, or both) at any time between
1964and2004inSwedenorbetween1977and2004in
Denmark.
Ulcerative colitis outcomes
As for the appendicectomies, we identified ulcerative
colitis outcomes in the hospital discharge registries. In
both countries, we included haemorrhagic proctitis as
part of the definition of ulcerative colitis. Specifically,
ulcerative colitis outcomes in Sweden were identified
under national ICD-7 codes 572.20, 572.21, or 578.03
(period1964-8),ICD-8codes563.10or569.02(period
1969-86),ICD-9group556(period1987-96),andICD-
10 group K51 (period 1997-2004). In Denmark,
ulcerative colitis outcomes were identified under
national ICD-8 codes 563.19 or 569.04 (period 1977-
93)andICD-10codesK51-K518B(period1994-2004).
Because associations with appendicectomy differ
Age at appendicectomy (years)
R
a
t
e
 
r
a
t
i
o
0-9 10-9 20-9 30-9 40-9 >50
0
0.2
0.4
0.6
0.8
1.2
1.4
1.0
Fig 1 | Rate ratios with 95% confidence intervals for ulcerative
colitis by age at appendicectomy (10 year age intervals)
adjusted for country (Sweden v Denmark), sex, attained age
(10 year intervals), calendar period (<1970, 1970-9, 1980-9,
1990-9, 2000-4), and time since appendicectomy (<0.5, 0.5-
<1, 1-4, 5-9, 10-14, 15-19, ≥20 years). Reference rate was rate
of ulcerative colitis among patients who underwent
appendicectomy at age ≥50
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disease,
3410we restricted our analysis to patients with
unambiguous records of ulcerative colitis. Conse-
quently, we excluded patients with ICD codes for
both ulcerative colitis and Crohn’s disease from all
analyses. We also excluded patients with indetermi-
nate colitis codes only. Using these stringent defini-
tions, we identified 31577 first inpatient hospital
contacts for ulcerative colitis in Sweden in 1964-2004
and 16808 in Denmark in 1977-2004. Based on the
distribution of sex, age, and calendar year for patients
with ulcerative colitis and person time at risk in the
underlying general population, we generated a set of
incidenceratesforulcerativecolitisforeachcountryin
strataofsex,age(fiveyearintervals),andcalendaryear.
Statistical analysis
Weusedtwomeasuresfortherelativeriskofulcerative
colitis in the appendicectomy cohort and the cohort
with familial predisposition to inflammatory bowel
disease.Weusedthestandardisedincidenceratio(SIR)
to compare the incidence of ulcerative colitis in these
cohorts with the incidence in the underlying general
population (external comparison) and rate ratios to
study differences in rates between cohort categories
(internal comparison).
Standardised incidence ratio
This ratio was calculated as the ratio of the observed
numberofdiagnosesofulcerativecolitistothenumber
expected based on background rates in the general
population. For the appendicectomy cohort, each
member contributed person time at risk for ulcerative
colitis from the first day of the month after the
appendicectomy until death or 31 December 2004,
whichever came first. For the cohort with a familial
predisposition, follow-up periods depended on the
affected relative. For those with a parent with
inflammatory bowel disease, follow-up started at
birthoronthedatewhentherelevantnational(Danish
relatives) or regional (Swedish relatives) hospital
discharge register started, whichever came later. For
those with a sibling (but no parent) with inflammatory
bowel disease, follow-up started at birth or the date of
diagnosisin the affected sibling,whichever came later.
For all individuals with a familial predisposition,
follow-up continued until death or 31 December
2004, whichever came first.
Person years at risk were summed for cohort
members and tabulated in strata of sex, age (five year
intervals), and calendar year. Person years for specific
groups were then multiplied by the corresponding
rates of ulcerative colitis for that specific group in the
general population and summed over strata to yield
expected numbers in the cohort. The standardised
incidence ratio was the ratio of the observed to the
expectednumberofcasesinthecohort.Wecalculated
these ratios separately in Sweden and Denmark using
country specific background incidence rates and
combined estimates obtained by dividing the sum of
observedcasesbythesumofexpectedcasesinthetwo
countries.Wepresentstandardisedincidenceratiosfor
the appendicectomy cohort by country, sex, age at
appendicectomy, time since appendicectomy, and
underlying disease. For all estimates, we calculated
95%confidenceintervals,assumingaPoissondistribu-
tion of the observed cases in the cohort.We compared
ratiosacrossstrataofexplanatoryvariablesusingWald
tests for homogeneity as simple one factor log linear
Poisson regressions on the observed cases with means
proportionalto the stratum specific expected numbers
ofcasesinthecohort.Thisisequivalenttousingthelog
ofstratumspecificnumbersofexpectedcasesasoffset.
Rate ratios
For more complex comparisons of rates of ulcerative
colitis in the appendicectomy cohort we performed
multiplePoissonregressionswithoffsetvariablesequal
to the log of the expected number of cases in strata of
the examined explanatory variable and the potential
Table 1 |Selected characteristics for study cohort of 709353 appendicectomy patients,
Sweden (1964-2004) and Denmark (1977-2004). Figures are numbers (percentages) of
patients
Sweden Denmark Both countries
Women 245 623 (55.4) 152 256 (57.3) 397 879 (56.1)
Men 198 138 (44.6) 113 336 (42.7) 311 474 (43.9)
Year of appendicectomy:
1964-7 10 364 (2.3) — 10 364 (1.5)
1968-70 10 605 (2.4) — 10 605 (1.5)
1971-3 21 593 (4.9) — 21 593 (3.0)
1974-6 34 654 (7.8) — 34 654 (4.9)
1977-9 42 019 (9.5) 37 675 (14.2) 79 694 (11.2)
1980-2 40 479 (9.1) 37 840 (14.2) 78 319 (11.0)
1983-5 42 228 (9.5) 35 364 (13.3) 77 592 (10.9)
1986-8 44 646 (10.1) 32 158 (12.1) 76 804 (10.8)
1989-91 41 018 (9.2) 28 357 (10.7) 69 375 (9.8)
1992-4 39 599 (8.9) 24 657 (9.3) 64 256 (9.1)
1995-7 36 802 (8.3) 22 535 (8.5) 59 337 (8.4)
1998-2000 36 949 (8.3) 21 764 (8.2) 58 713 (8.3)
2001-4 42 805 (9.6) 25 242 (9.5) 68 047 (9.6)
Age (years) at appendicectomy:
0-9 34 092 (7.7) 24 311 (9.2) 58 403 (8.2)
10-9 121 179 (27.3) 76 966 (29.0) 198 145 (27.9)
20-9 91 317 (20.6) 47 752 (18.0) 139 069 (19.6)
30-9 64 324 (14.5) 36 493 (13.7) 100 817 (14.2)
40-9 51 027 (11.5) 27 444 (10.3) 78 471 (11.1)
≥50 81 822 (18.4) 52 626 (19.8) 134 448 (19.0)
Underlying disease:
Appendicitis:
All 296 367 (66.8) 183 168 (69.0) 479 535 (67.6)
With perforation 54 934 (12.4) 38 300 (14.4) 93 234 (13.1)
Without perforation 241 433 (54.4) 144 868 (54.5) 386 301 (54.5)
Mesenteric lymphadenitis 24 064 (5.4) 8 119 (3.1) 32 183 (4.5)
Other disease* 123 330 (27.8) 74 305 (28.0) 197 635 (27.9)
Appendiceal disease except
appendicitis
1868 (0.4) 1222 (0.5) 3090 (0.4)
Unspecific abdominal pain 28 212 (6.4) 13 433 (5.1) 41 645 (5.9)
Other/unspecified disease 93 250 (21.0) 59 650 (22.5) 152 900 (21.6)
*Other than appendicitis or mesenteric lymphadenitis.
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calendar period, time since appendicectomy, and age
at appendicectomy. Hereby we obtained rate ratios
and95%confidenceintervalsforcomparisonsbetween
groups of appendicectomy cohort members with
different profiles of explanatory variables and con-
founders.
We also used multiple Poisson regression to obtain
rate ratios and 95% confidence intervals for the
evaluation of the impact of appendicectomy and the
disease underlying the appendicectomy on risk in the
cohort with familial predisposition to inflammatory
bowel disease. Specifically, in this cohort we modelled
theobservednumbersofstratumspecificcasesasalog
linear function of attained age, calendar period, and
appendicectomy status, using the log of the stratum
specificpersonyearsatriskinthepredisposedcohortas
offset.
All computations were carried out in SAS, versions
8.2 and 9.1 (SAS Institute, Cary, NC). Poisson
regression analyses and 95% confidence intervals of
standardised incidence ratios and rate ratios were
calculated with the GENMOD procedure. We con-
sidered confidence intervals that excluded unity and
two sided P values <0.05 as significant.
RESULTS
The Swedish and Danish cohorts comprised 709353
patientswhohadundergoneappendicectomy(table 1).
Inbothcountries,therewasamoderatepredominance
of females (55.4% in Sweden, 57.3% in Denmark). In
recentyears(2001-4)around10700appendicectomies
were performed each year in Sweden with its 9.0
millioninhabitants(crudeannualappendicectomyrate
1190/million) compared with about 6300 appendicec-
tomies per year in Denmark with its 5.4 million
Table 2 |Standardised incidence ratios (SIR) of ulcerative colitis among 709353 appendicectomy patients, Sweden (1964-
2004) and Denmark (1977-2004)
Person years Observed Expected SIR (95% CI) P value*
Total 11 078 855 1192 1352.3 0.88 (0.83 to 0.93)
Sweden 7 250 881 840 958.4 0.88 (0.82 to 0.94)
0.76
Denmark 3 827 974 352 393.9 0.89 (0.80 to 0.99)
Women 6 467 929 677 762.9 0.89 (0.82 to 0.96)
0.79
Men 4 610 926 515 589.5 0.87 (0.80 to 0.95)
Age (years) at appendicectomy:
<10 952 028 38 75.1 0.51 (0.37 to 0.70)
<0.001
10-9 3 358 272 205 381.4 0.54 (0.47 to 0.62)
20-9 2 376 137 288 324.6 0.89 (0.79 to 1.00)
30-9 1 672 986 223 211.0 1.06 (0.93 to 1.21)
40-9 1 267 122 168 148.4 1.13 (0.97 to 1.32)
≥50 1 452 309 270 211.9 1.27 (1.13 to 1.44)
Years since appendicectomy:
<0.5 351 008 76 37.2 2.04 (1.63 to 2.56)
<0.001
0.5-<1 344 872 59 36.8 1.60 (1.24 to 2.07)
1-4 2 554 495 319 285.7 1.12 (1.00 to 1.25)
5-9 2 687 351 296 329.1 0.90 (0.80 to 1.01)
10-4 2 129 600 191 274.1 0.70 (0.60 to 0.80)
15-9 1 536 293 120 197.1 0.61 (0.51 to 0.73)
≥20 1 475 237 131 192.4 0.68 (0.57 to 0.81)
Underlying disease:
Appendicitis:
All 7 188 320 726 876.4 0.83 (0.77 to 0.89)
<0.001†
With perforation 1 234 469 111 149.4 0.74 (0.62 to 0.89)
Without perforation 5 953 851 615 727.0 0.85 (0.78 to 0.92)
Mesenteric lymphadenitis 645 698 48 74.3 0.65 (0.49 to 0.86)
Other disease‡ 3 244 837 418 401.6 1.04 (0.95 to 1.15)
Appendiceal disease except
appendicitis
43 437 6 5.5 1.09 (0.49 to 2.43)
Unspecific abdominal pain 654 377 93 81.5 1.14 (0.93 to 1.40)
Other/unspecified disease 2 547 023 319 314.7 1.01 (0.91 to 1.13)
*Test for homogeneity.
†In test for homogeneity with categorisation in three (appendicitis, mesenteric lymphadenitis, other disease) or six (appendicitis with perforation,
appendicitis without perforation, mesenteric lymphadenitis, appendiceal disease except appendicitis, unspecific abdominal pain, other and
unspecified disease) groups of underlying disease.
‡Other than appendicitis or mesenteric lymphadenitis.
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appendicectomy and underlying disease were largely
similar in the two countries.
Standardised incidence ratios of ulcerative colitis after
appendicectomy
Bycountryandsex—Thecombinedcohortwasfollowed
for the occurrence of ulcerative colitis for 11.1 million
person years after appendicectomy (table 2), with an
average follow-up of 16.3 years in Sweden and 14.
4years inDenmark.Overall, witha totalof1192 cases
occurringinthetwocountries,thecruderatewas10.8/
100000 person years. The incidence of ulcerative
colitis in people who had undergone appendicectomy
was12%lowerinSweden(standardisedincidenceratio
0.88, 95% confidence interval 0.82 to 0.94) and 11%
lower in Denmark (0.89, 0.80 to 0.99), with no
significant difference between the two countries
(P=0.76). As associations in the two countries were
similar, we present all subsequent results for the
combined cohort.
By age at appendicectomy—Appendicectomies per-
formed in childhood or adolescence were associated
with almost 50% reduction in incidence of ulcerative
colitis (0.51, 0.37 to 0.70, and 0.54, 0.47 to 0.62, for
appendicectomiesbeforetheageof10andfromage10
to 19, respectively). Standardised incidence ratios
gradually increased with age at appendicectomy
(P<0.001) with no indication of a reduced incidence
ofulcerativecolitisincohortmembersaged30ormore
at appendicectomy. Indeed, patients who underwent
appendicectomy at or after the age of 50 had a
significantlyhigherincidencethancomparablesubsets
of the general population (1.27, 1.13 to 1.44).
By time since appendicectomy—Standardised incidence
ratiosdependedsignificantlyonthetimeintervalsince
the appendicectomy (P<0.001). The risk of ulcerative
colitis was higher in the first five years after appendi-
cectomy—notably, in the first six months after the
operation (2.04, 1.63 to 2.56)—whereas it was consis-
tently reduced in time intervals 10 or more years after
appendicectomy.
Byunderlyingdisease—Theincidenceratioalsovaried
considerably according to the underlying disease
leading to the appendicectomy. About 68% of cohort
memberswhohadsurgerybecauseofappendicitishad
significantly reduced incidence (0.83, 0.77 to 0.89).
Likewise, cohort members with a diagnosis of mesen-
teric lymphadenitis were at reduced risk (0.65, 0.49 to
0.86). In contrast, those who had surgery for reasons
other than appendicitis or mesenteric lymphadenitis
experienced no unusual risk (1.04, 0.95 to 1.15).
Rate ratios of ulcerative colitis by age <20 v ≥20 at
appendicectomy
We used Poisson regression analysis to explore the
association with age at appendicectomy further.
Compared with people in the oldest category (≥
50 years), rate ratios were significantly lower for
patients aged 0-9 (0.30, 0.17 to 0.55) or 10-19 (0.41,
0.27to0.64)atappendicectomy(fig1),afteradjustment
forpotentialconfoundingbycountry,sex,attainedage,
calendar period, and time since the operation. We
subsequently analysed rates of ulcerative colitis
according to time since appendicectomy with cohort
members dichotomised into those who underwent
appendicectomy during childhood or adolescence (<
20 years) or during adulthood (≥20 years). In both
groups rate ratios declined with time since appendi-
cectomy (fig 2). In the Poisson regression model, the
term for statistical interaction between age at appendi-
cectomy (<20 v ≥20 years) and time since appendi-
cectomy (in one year intervals) was not significant
(P=0.17), implying that the curves for the two groups
can be considered to be parallel. Thus, in the resulting
reduced Poisson model, the main effect of age at
appendicectomy was significant (P<0.001), reflecting
that rates were consistently lower among people who
underwent appendicectomy before the age of 20.
Standardised incidence ratios of ulcerative colitis after
appendicectomy at age <20
Becausetheriskofulcerativecolitiswasunremarkable
among patients who underwent appendicectomy at or
after the age of 20 (standardised incidence ratio 1.06,
0.99to1.13),wecarriedoutsupplementaryanalyseson
cohortmemberswhohadundergoneappendicectomy
before the age of 20 (table 3). Risk after appendicect-
omy in childhood or adolescence was reduced for
women(0.59,0.50to0.70)andmen(0.47,0.39to0.57).
As for the entire appendicectomy cohort, rates of
ulcerativecolitisdeclinedwithtimesincetheoperation
(P<0.001),butincidenceratioswerealreadylowerone
year after appendicectomy and remained significantly
so from five years after. Rates were reduced by 71% in
the long term follow-up period ≥20 years after the
operation (0.29, 0.19 to 0.43). Appendicectomy for
appendicitis with perforation (0.39, 0.25 to 0.61),
appendicitis without perforation (0.46, 0.39 to 0.55),
or mesenteric lymphadenitis (0.65, 0.46 to 0.90) were
each associated with significant reduction in risk,
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Fig 2 | Rate ratios for ulcerative colitis by time since
appendicectomy in one year intervals for patients aged <20 or
≥20 at appendicectomy, adjusted as in fig 1. Reference rate
was rate of ulcerative colitis five years after appendicectomy
among those aged ≥20. P<0.001 reflects significance of effect
of age at appendicectomy (<20 v ≥20) obtained in slightly
reduced regression model with similar effect of time since
appendicectomy in compared groups
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(0.86, 0.66 to 1.12).
Rate ratios of ulcerative colitis by age and underlying
disease
Having found evidence of low risk among people who
underwent appendicectomy in childhood and adoles-
cence and among those who were operated on for
appendicitis or mesenteric lymphadenitis, we used
Poisson regression to evaluate the role of the under-
lying disease in subsets of young(<20 years) and older
(≥20)patients(fig 3).Amongthe youngerpatients,risk
was significantly lower in those with appendicitis or
mesenteric lymphadenitis compared with those with
other disease (P<0.001). In contrast, among older
patients, there was no significant difference in rates
between those with underlying appendicitis or mesen-
teric lymphadenitis and those without (P=0.48).
Role of appendicectomy in people with familial
predisposition
To address the impact of appendicectomy in people
with a familial predisposition to ulcerative colitis, we
studied risk among 224483 individuals whose parents
(one or both) or siblings (one or more) had inflamma-
toryboweldisease.Asanticipated,thenumberofcases
during 4.2 million person years of follow-up in this
predisposed cohort clearly exceeded the expected
number based on rates in the underlying general
populationsofSwedenandDenmark(1404observedv
446 expected; standardised incidence ratio 3.15, 2.99
to3.32).Asseenintable 4,Poissonregressionanalysis
controlledforage,calendarperiod,andtypeofrelative
showed no difference between rates in relatives who
retained their appendix intact (reference group) and
relatives who underwent appendicectomy without
appendicitis (rate ratio 1.04, 0.66 to 1.55). In contrast,
risk in relatives who underwent appendicectomy for
appendicitis was significantly reduced (0.49, 0.31 to
0.74),apatternseenwhethertheaffectedrelativewasa
parent (0.43, 0.22 to 0.75) or a sibling (0.54, 0.27 to
0.96). By introducing interaction terms in the Poisson
regression models between appendicectomy status on
one side and country (P=0.67) or sex (P=0.16) on the
other, we found that the observed risk reduction
associated with appendicectomy for appendicitis (v
no appendicectomy) was consistent for Swedish (0.45,
0.25 to 0.73) and Danish (0.63, 0.27 to 1.24) relatives
and identical for female (0.49, 0.25 to 0.87) and male
(0.49, 0.26 to 0.85) relatives of patients with inflamma-
tory bowel disease.
DISCUSSION
Key findings
The inverse association between appendicectomy and
risk of ulcerative colitis was first reported around
20 years ago.
11 The present bi-national cohort study
accordswithandexpandspreviousfindingsincountry
specific analyses.
34In agreement with most published
case-control studies
2 we observed significantly fewer
subsequent diagnoses in patients who had undergone
appendicectomy, the association being restricted to
Table 3 |Standardised incidence ratios (SIR) of ulcerative colitis among 357825 patients who underwent appendicectomy
before age 20 years, Sweden (1964-2004) and Denmark (1977-2004)
Person years Observed Expected SIR (95% CI) P value*
Total 4 310 300 243 456.4 0.53 (0.47 to 0.60)
Sweden 2 689 371 169 321.5 0.53 (0.45 to 0.61)
0.76
Denmark 1 620 929 74 135.0 0.55 (0.44 to 0.69)
Women 2 247 490 139 234.2 0.59 (0.50 to 0.70)
0.07
Men 2 062 810 104 222.2 0.47 (0.39 to 0.57)
Years since appendicectomy:
<0.5 127 430 9 5.7 1.57 (0.82 to 3.02)
<0.001
0.5-<1 125 978 8 6.2 1.28 (0.64 to 2.57)
1-4 953 681 56 65.2 0.86 (0.66 to 1.12)
5-9 1 039 320 70 106.6 0.66 (0.52 to 0.83)
10-4 855 438 51 110.2 0.46 (0.35 to 0.61)
15-9 626 117 27 85.6 0.32 (0.22 to 0.46)
≥20 582 335 22 76.9 0.29 (0.19 to 0.43)
Underlying disease:
Appendicitis:
All 3 234 360 154 340.1 0.45 (0.39 to 0.53)
<0.001†
With perforation 507 926 19 49.0 0.39 (0.25 to 0.61)
Without perforation 2 726 434 135 291.1 0.46 (0.39 to 0.55)
Mesenteric lymphadenitis 486 030 34 52.7 0.65 (0.46 to 0.90)
Other disease‡ 589 910 55 63.7 0.86 (0.66 to 1.12)
Unspecific abdominal pain 264 039 25 29.1 0.86 (0.58 to 1.27)
*Test for homogeneity.
†Test for homogeneity with categorisation in three groups of underlying disease (appendicitis, mesenteric lymphadenitis, other disease).
‡Other than appendicitis or mesenteric lymphadenitis.
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phadenitis before the age of 20. Others have observed
thisagerestriction,
12-14butwealsoshowedthatwithout
appendicitis or mesenteric lymphadenitis, appendi-
cectomy has no impact on subsequent risk, even when
done in childhood or adolescence. The analysis of risk
in individuals with a familial predisposition to inflam-
matory bowel disease corroborates this view. In this
geneticallypredisposedcohort,therewasnoreduction
in ulcerative colitis associated with appendicectomy
without underlying appendicitis but, as with the
general population who experienced a significant
55% reduction in risk after appendicectomy for
appendicitis before the age of 20 (standardised
incidence ratio 0.45, 0.39 to 0.53), we observed a
significant51%reductioninriskafterappendicectomy
for appendicitis in the cohort with a familial predis-
position (rate ratio 0.49, 0.31 to 0.74). Thus, our
findings consistently show that removal of the appen-
dix itself is not responsible for the inverse association.
Rather, for reasons that remain unclear, appendicitis
and mesenteric lymphadenitis seem to be associated
with a reduced subsequent risk of ulcerative colitis.
Despitedecadesofefforttounderstanditsaetiology,
the causes of ulcerative colitis remain poorly char-
acterised. While higher rates in first degree relatives of
probands with the disease strongly suggest important
genetic components, the lack of affected relatives
among most patients with a new diagnosis
1516 and
concordance rates of only 7%-18% among monozygo-
tic twins
17-19 e m p h a s i s et h er o l eo fn o n - i n h e r i t e d
factors. Psychological susceptibility factors and many
environmental risk factors have been proposed,
including infectious agents, factors associated with
urban lifestyle, high socioeconomic status, consump-
tionofhighsugardiets,softdrinks,chocolate,chewing
gum, toothpaste, and oral contraceptives.
20 While the
evidence does not support any specific environmental
risk factor as genuinely associated with increased risk,
two other factors, tobacco smoking and a history of
appendicectomy have been consistently associated
with reduced risk.
1
Possible mechanisms linking appendicitis in childhood to
low risk of ulcerative colitis
Theoretically, several mechanisms might explain why
risk is low in people with a history of appendicitis in
childhood or adolescence, and these mechanisms
might apply to other childhood inflammatory condi-
tions seen merely as unspecific inflammation of
mesenteric lymph nodes. One mechanism could be
thatinflammatoryresponseselicitedduring thecourse
ofchildhoodappendicitisormesentericlymphadenitis
somehow induce longlasting immunological changes
in the colonic mucosa, which eventually protect these
individuals from developing ulcerative colitis (bene-
ficialinflammationhypothesis).Althoughtheoretically
possible, to the best of our knowledge there is no
evidence to support this hypothesis.
A second mechanism could be that an, as yet,
uncharacterised genetic trait that confers protection
against ulcerative colitis might be closely linked to
susceptibility genes for appendicitis or, in reverse,
susceptibility genes for ulcerative colitis might be
closelylinkedtoanunknowngenetictraitthatprotects
against appendicitis (linkage disequilibrium hypoth-
esis). Future large scale family studies of the inter-
relations between ulcerative colitis and appendicitis
might help to clarify the relevance of this hypothesis.
Thirdly,anaetiologicalmechanismmightinvolvean
environmental or microbial factor associated with
increased risk of appendicitis and reduced risk of
ulcerativecolitisorthereverse,afactorassociatedwith
protection against appendicitis and increased risk
(antagonistic risk factor hypothesis). However, we are
aware of no empirical evidence favouring any such
environmental or microbial candidate.
Finally, constitutional factors associated with a
preference for immune responses orchestrated by
Th1 or Th2 cells, might differ between patients
developing appendicitis and those developing ulcera-
tive colitis (constitutional immunity hypothesis). In
favourofthisidea,immuneresponsescharacterisedby
Th2 activation are generallyconsideredto bea feature
inthepathogenesisofulcerativecolitis.
21-23Incontrast,
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Fig 3 | Rate ratios for ulcerative colitis by time since
appendicectomy in two year intervals according to underlying
disease in patients aged <20 (P<0.001) or ≥20 (P=0.48) at
appendicectomy. Rate ratios adjusted for country (Sweden v
Denmark), sex, attained age (10 year intervals), calendar
period (<1970, 1970-9, 1980-9, 1990-9, 2000-4), and age at
appendicectomy. Reference rate was rate of ulcerative colitis
four to five years after appendicectomy among patients with
other disease. P values reflect significance of effect of
underlying disease (appendicectomy or mesenteric
lymphadenitis v other disease) obtained in slightly reduced
regression models with similar effect of time since
appendicectomy in compared groups
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latedinappendicitis.Tumournecrosisfactoralphahas
beenshowntobeasensitivemarkerofinflammationin
appendicitis,
24 and the tendency among individuals
with a history of appendicitis to produce high
concentrations of interferon γ on stimulation with
tetanus toxoid more than four months after
appendicitis
25 provides indirect support for the idea
that a constitutional preference for Th1 dominated
immune responses might characterise those who
develop appendicitis. Obviously, dichotomisation of
individuals in immunologically distinct categories
based on the Th1/Th2 paradigm is highly simplistic
considering the immense complexity of the immune
system.
26Detailedimmunologicaldatatoaddressthese
speculations are needed.
Strengths of the study
The prospective nature of our historical cohort
analyses eliminated potential information and selec-
tionbiasesandothermethodologicalproblemsthatare
often encountered in case-control studies. Other
strengths include the size of our cohort and the truly
population based data sources we used to characterise
cohort members and identify ulcerative colitis out-
comes. Specifically, by combining data from Sweden
and Denmark and extending the follow-up period to
theendof2004,ourstudycomprisedthreetofivetimes
more participants, four to 11 times more observation
time at risk, and four to 14 times more outcomes than
the only two previously conducted national cohort
studies.
34 The combination of Swedish and Danish
data resulted in a huge dataset with sufficient statistical
power to detect even minor deviations from unity as
significant. Before combining data from the two
countries,wefirstcalculatedallstandardisedincidence
ratios in country specific analyses, and results were
similar in the two countries in almost all strata of
examined explanatory variables. The only exception
was the reduced risk after appendicectomy for
mesenteric lymphadenitis, which was seen only in the
larger Swedish cohort. Consistency between country
specific standardised incidence ratios in all other
analyses lends robustness and credibility to the
reported associations.
In addition to presenting conventional standardised
incidence ratios to compare rates of ulcerative colitis
betweenpatientsundergoingappendicectomyand the
general population, we also compared rates between
strata of the appendicectomy cohort by means of
Poissonregression.Whilethe analyses of standardised
incidence ratios showed significant reductions in risk
with young age at appendicectomy and with appendi-
citis or mesenteric lymphadenitis as the underlying
disease, the Poisson analyses expanded these findings,
showing that both factors had to be present to confer a
low risk of ulcerative colitis. In other words, appendi-
cectomy in a young person without appendicitis or
mesenteric lymphadenitis is not linked to low subse-
quent risk, just as appendicitis or mesenteric lympha-
denitis leading to appendicectomy in adulthood
carried no risk reduction. Our finding that appendi-
cectomy is associated with reduced risk only in
children and adolescents with appendicitis or mesen-
teric lymphadenitis, combined with the other novel
observationofnoriskreductionafterremovalofanon-
inflamed appendix in people with a familial predis-
position to inflammatory bowel disease, render as
implausibleanyspeculationsaboutpossiblebenefitsof
prophylactic removal of a healthy appendix in people
with a predisposition to ulcerative colitis.
Limitations of the study
Ourstudyhassomelimitations.Wereliedonroutinely
collecteddatafromhealthandadministrativeregisters,
which are not primarily set up for research purposes.
Consequently, to the extent appendicectomy reports
and diagnoses of appendicitis or mesenteric lympha-
denitiswereincorrectlyrecordedorentirelymissingin
the files of the hospital registries, the observed
significant inverse associations with subsequent risk
will be conservatively estimated. Swedish discharge
diagnoses of appendicitis have been estimated to
include about 10% false positives and 6% false
negatives.
27Likewise,thediagnosesofulcerativecolitis
we used as outcomes in the study have a diagnostic
specificity of around 90% in both countries,
2829 which
leaveslittleroomfornon-differentialmisclassification.
Considering the prospective nature of the study,
plausible mechanisms that would lead to differential
over or under-reporting of diagnoses according to
Table 4 |Rate ratios* (RR) with 95% confidence intervals for ulcerative colitis according to appendicectomy status in cohort of
224483 people with familial predisposition to inflammatory bowel disease, Sweden (1964-2004) and Denmark (1977-2004).
Figures are numbers of cases of ulcerative colitis per person years at risk
Relative with
inflammatory
bowel disease
No appendicectomy Appendicectomy, no appendicitis Appendicectomy + appendicitis
Cases/person
years RR (95% CI)
Cases/person
years RR (95% CI)
Cases/person
years RR (95% CI)
Parent or sibling† 1361/4 047 047 1‡ 22/52 608 1.04 (0.66 to 1.55) 21/102 211 0.49 (0.31 to 0.74)
Parent 854/2 803 351 1‡ 12/30 195 1.01 (0.54 to 1.71) 11/61 385 0.43 (0.22 to 0.75)
Sibling 551/1 281 094 1‡ 10/23 118 1.01 (0.51 to 1.79) 10/42 050 0.54 (0.27 to 0.96)
*Adjusted for age, calendar period (both in one year intervals with restricted cubic splines), and type of relative with inflammatory bowel disease
(parent, sibling, or both).
†Some cases of ulcerative colitis (n=44) occurred in patients with familial predisposition to inflammatory bowel disease through both parent and
sibling.
‡Reference category.
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Another possible limitation is that the hospital
discharge data we used to identify patients with
ulcerative colitis account only for those treated as
inpatients.Theoretically,therefore,ourfindingsmight
not apply to milder cases of ulcerative colitis treated
only in ambulatory clinics or specialist settings. This
potential limitation is not specific to our study,
however, as the available literature on the subject is
based almost entirely on hospital data.
Like most previous studies we were unable to adjust
for smoking, the only behavioural factor that has been
linkedratherconsistentlytorisk.
1Theoretically,there-
fore, if smoking is also associated with appendicitis or
mesenteric lymphadenitis
30 our estimates of rate ratios
might be confounded by tobacco smoking. Major
confounding, however, is unlikely because a strong
inverse association between appendicectomy and risk
was also observed in previous studies that took
smoking into account.
3132 Also, in light of the
considerably higher prevalence of smokers in Den-
markthaninSweden(35%v19%amongmenand43%
v25%amongwomenaged≥25years),
33itisreassuring
that we obtained almost identical results in country
specific analyses.
Clinical implications
Our study has not only aetiological but also clinical
implications. By dismissing appendicectomy itself as
an explanation for the repeatedly observed inverse
association, our findings should put an end to specula-
tions about possible prophylactic capabilities of
appendicectomy.
34-37 Among members of the general
population in Sweden and Denmark we found no
evidenceofreducedincidenceinpeoplewhohadhada
non-inflamed appendix removed. We also found no
indication that removal of a non-inflamed appendix
would reduce the threefold increasedrisk of ulcerative
colitis in genetically predisposed individuals.
Future research
Hopefully, future studies will be able to replicate and
extendourfindingsusingotherhighqualitypopulation
based data. Our novel observation that appendicect-
omy in the absence of appendicitis provided no
protection against ulcerative colitis in relatives of
patients with inflammatory bowel disease was
consistently seen in Sweden and Denmark and in
men and women. Confirmatory findings in other high
risk populations would strengthen the generalisability
of our findings. Also, knowledge about risk of
ulcerative colitis in relatives of patients with appendi-
citis might improve our understanding of the under-
lying mechanism behind the inverse association. A
betterunderstandingoftheimmunological,genetic,or
other mechanisms that protect young patients with
appendicitis against later development of ulcerative
colitis, regardless of whether they carry a familial
predisposition or not, might turn out not only to be
useful in attempts to understand the aetiology of
ulcerative colitis. Such insight might at the same time
provide clues to the aetiology of appendicitis. Of
immediate clinical importance, our study should
discourage doctors from considering appendicectomy
asapossiblemeasureofpreventingulcerativecolitisin
families affected by the disease.
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